Your browser doesn't support javascript.
loading
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.
Novak, Frederik; Bajwa, Hamza Mahmood; Coia, John Eugenio; Nilsson, Anna Christine; Nielsen, Christian; Holm, Dorte K; Østergaard, Kamilla; Hvidt, Mathilde Vilhelmine Miller; Byg, Keld-Erik; Johansen, Isik S; Mittl, Kristen; Rowles, William; Zamvil, Scott S; Bove, Riley; Sabatino, Joseph J; Sejbaek, Tobias.
  • Novak F; Neurology, Southwest Jutland Hospital, Esbjerg, Region of Southern Denmark, Denmark.
  • Bajwa HM; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Coia JE; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Nilsson AC; Department of Neurology, Southwest Jutland Hospital, Esbjerg, Denmark.
  • Nielsen C; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Holm DK; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Østergaard K; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Hvidt MVM; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Byg KE; Department of Neurology, Nordsjællands Hospital, Hillerod, Denmark.
  • Johansen IS; Neurology, Hospitalsenhed Midt, Viborg, Denmark.
  • Mittl K; Department of Rheumatology, Odense Universitetshospital, Odense, Denmark.
  • Rowles W; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Zamvil SS; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Bove R; Department of Neurology, University California San Francisco, San Francisco, California, USA.
  • Sabatino JJ; Department of Neurology, University California San Francisco, San Francisco, California, USA.
  • Sejbaek T; Department of Neurology, University California San Francisco, San Francisco, California, USA.
J Neurol Neurosurg Psychiatry ; 94(11): 934-937, 2023 11.
Article en En | MEDLINE | ID: mdl-37185261
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article